August 16, 2016

Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13

The second generation device is less than half the weight and half the size of the first generation Optune System The second generation device is less than half the weight and half the size of the first generation Optune System (Photo: Business Wire) August… Read More
learn more
August 16, 2016

Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13

The second generation device is less than half the weight and half the size of the first generation Optune System The second generation device is less than half the weight and half the size of the first generation Optune System (Photo: Business Wire) August… Read More
learn more
August 16, 2016

Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13

The second generation device is less than half the weight and half the size of the first generation Optune System The second generation device is less than half the weight and half the size of the first generation Optune System (Photo: Business Wire) August… Read More
learn more
August 8, 2016

Novocure to Present at Upcoming Investor Conferences

August 08, 2016 04:05 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will present at three upcoming investor conferences in August and September. William Doyle, Novocure’s Executive Chairman, will… Read More
learn more
August 8, 2016

Novocure to Present at Upcoming Investor Conferences

August 08, 2016 04:05 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will present at three upcoming investor conferences in August and September. William Doyle, Novocure’s Executive Chairman, will… Read More
learn more
August 8, 2016

Novocure to Present at Upcoming Investor Conferences

August 08, 2016 04:05 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will present at three upcoming investor conferences in August and September. William Doyle, Novocure’s Executive Chairman, will… Read More
learn more
July 28, 2016

Novocure to Host Research and Development Day on Dec. 12, 2016

July 28, 2016 06:25 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:NVCR) announced today that the company will hold a research and development day for analysts and investors on Monday, Dec. 12, 2016, from 1 to 4 p.m. EST… Read More
learn more
July 28, 2016

Novocure to Host Research and Development Day on Dec. 12, 2016

July 28, 2016 06:25 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:NVCR) announced today that the company will hold a research and development day for analysts and investors on Monday, Dec. 12, 2016, from 1 to 4 p.m. EST… Read More
learn more
July 28, 2016

Novocure to Host Research and Development Day on Dec. 12, 2016

July 28, 2016 06:25 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:NVCR) announced today that the company will hold a research and development day for analysts and investors on Monday, Dec. 12, 2016, from 1 to 4 p.m. EST… Read More
learn more
July 28, 2016

Novocure Reports Second Quarter 2016 Financial Results and Provides Company Update

Three months ended June 30, Continued growth in active patients with 891 active patients at June 30, 2016, an increase of 110 percent from second quarter 2015, and 12 percent from first quarter 2016 Second quarter 2016 reported revenues of $17.9 million, reflecting 174 percent growth… Read More
learn more